TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good -- great. Good afternoon, everyone, and welcome to the 4:40 p.m. session at Day 3 of the Goldman Sachs Global Healthcare Conference. It's our last session of the conference, but I always like to say, save the best for last. I've got the pleasure of hosting a fireside chat today with TG Therapeutics. And with me, joining from the company is Michael Weiss. He's Chief Executive Officer.
And so maybe before we get into detailed questions about the company, Michael, you and I have known each other for quite some time. You've helped cofound the company, actually, back in 2011, and we met sometime in 2013 or maybe 2014.
So as we find ourselves here in mid-2020, maybe if you could start off by providing some reflections of kind of the vision for the company as you cofounded it, and where you've come -- from there, where you are now. So I'll turn it to you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |